Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 2/20 | 0.36 |
| ▸ | CDC25B | P30305 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 6/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.35 |
| ▸ | RAB9A | P51151 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | MAP2K7 | O14733 | 1/20 | 0.35 |
| ▸ | GMNN | O75496 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18622284 | 0.66 | — | — | |
| SCHEMBL11761594 | 0.64 | — | — | |
| SCHEMBL9655485 | 0.63 | CDC25A (0.64) | CDC25ACDC25BMAPTALDH1A1KDM4E | |
| SCHEMBL5590298 | 0.63 | CDC25A (0.56) | CDC25ACDC25BMAPTALDH1A1KDM4E | |
| Ubiquinone Qo SCHEMBL49420 | 0.62 | HKDC1 (0.61) | CDC25ACDC25BMAPTALDH1A1KDM4E | |
| SCHEMBL14894669 | 0.61 | ALDH1A1 (0.50) | CDC25ACDC25BMAPTALDH1A1KDM4E | |
| SCHEMBL783100 | 0.60 | — | — | |
| Ubiquinone Qo SCHEMBL29631791 | 0.60 | HKDC1 (0.47) | CDC25ACDC25BMAPTALDH1A1KDM4E | |
| SCHEMBL12592463 | 0.59 | CDC25A (0.58) | CDC25ACDC25BMAPTALDH1A1KDM4E | |
| SCHEMBL3420496 | 0.59 | MAPT (0.58) | CDC25ACDC25BMAPTALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4146180-A1 | METHODS AND COMPOSITIONS FOR TREATING AN RNA VIRUS INDUCED DISEASE | Golden Biotechnology Corporation (US) | 2023-03-15 | — | — | EP | disclosed |
| WO-2021226412-A1 | METHODS AND COMPOSITIONS FOR TREATING AN RNA VIRUS INDUCED DISEASE | GOLDEN BIOTECHNOLOGY CORPORATION (US) | 2021-11-11 | — | — | WO | disclosed |
| EP-3541777-A1 | METHODS AND COMPOSITIONS FOR TREATING ATOPIC DERMATITIS | Golden Biotechnology Corporation (US) | 2019-09-25 | — | — | EP | disclosed |
| WO-2018094122-A1 | METHODS AND COMPOSITIONS FOR TREATING ATOPIC DERMATITIS | GOLDEN BIOTECHNOLOGY CORPORATION (US) | 2018-05-24 | — | — | WO | disclosed |
| WO-2014151304-A1 | THERAPEUTIC METHODS AND COMPOSITIONS UTILIZING CYCLOHEXENONE COMPOUNDS | GOLDEN BIOTECHNOLOGY CORPORATION (US) | 2014-09-25 | — | — | WO | disclosed |
| EP-2655309-A1 | METHODS AND COMPOSITIONS FOR TREATING LUNG CANCER | Golden Biotechnology Corporation (US) | 2013-10-30 | — | — | EP | disclosed |
| WO-2012039793-A1 | METHODS AND COMPOSITIONS FOR TREATING LUNG CANCER | GOLDEN BIOTECHNOLOGY CORPORATION (US) | 2012-03-29 | — | — | WO | disclosed |